Introduction
An uncommon and dreaded complication of cataract extraction and intraocular lens implantation is fungal endophthalmitis. Outbreaks and individual case reports of fungal endophthalmitis due to filamentous fungi and yeasts, such 3s Candida, have been described [l-61. In most reports of fungal endophthalmitis associated with intraocular lens implantation, the outcome has been poor. One reason for this is possibly the poor penetration of most antifungal drugs into the eye [7-91. Fluconazole is a bis-triazole antifungal agent which has been shown to penetrate into both the vitreous body and aqueous humour of the eye [9, 101. We report on our experience with fluconazole in the treatment of four patients who had Candida parapsilosis endophthalmitis following cataract extraction with implantation of an intraocular lens.
Patients and methods
Four patients with culture-proven C. parapsilosis endophthalmitis following implantation of a posterior chamber intraocular lens were evaluated and treated between January 1989 and September 1990. Treatment was 400 mg of oral fluconazole daily, except in one patient who had renal insufficiency and received 200 mg daily.
Informed consent was obtained prior to beginning fluconazole therapy. Symptoms and ocular findings were followed monthly for the duration of therapy, which was one year in all patients, and follow-up was carried out for two years after therapy was completed.
Results
The four patients, three of whom were women, were 66 to 74 years of age (Table 1 ). All had undergone extracapsular cataract extraction and had a posterior chamber intraocular lens implanted. Following the implantation, visual acuity improved in all patients, but one to four months later all experienced a gradual decrease in visual acuity and patients 1, 3 and 4 had intraocular pain.
Over the course of their infection, all four patients had mild to moderate flare and cells in the anterior chamber, keratitic precipitates, and vitritis present. Patient 1 developed an hypopyon, and patient 3 developed a rhegmatogenous retinal detachment. Light perception was intact in all patients. Three patients could see only gross movement in the affected eye. None had any systemic symptoms, such as fever, weight loss or fatigue.
The diagnosis of Candida endophthalmitis was made by culture of the vitreous aspirate in two patients and by culture of the vitrectomy and posterior capsulotomy tissue in two patients. The diagnosis was not made until six months after lens implantation in three patients and ten months after implantation in the remaining patient. Prior to the diagnosis of Cundida infection, all patients had been treated with topical, paraocular or intravitreal cortiosteroids, and patients 1 and 3 had received oral prednisone.
After the diagnosis of Cundida endophthalmitis was made, initial antifungal treatment in all four patients was intravitreal amphotericin B; in addition, patient 1 had intravenous amphotericin B for one week and flucytosine for two weeks. All patients had transient improvement in vision, but then experienced decreasing visual acuity over the next four to six months. Intravitreal amphotericin B was given again in all patients with only transient improvement of vision.
In patient 1 the lens implant was removed, but in the other three patients the implant was not removed either because the patient was a poor operative risk (patients 2 and 4) or because of secondary problems of retinal detachment and low in traocular pressure (patient 3). with ocular pain had relief and all patients had improvement in visual acuity and a decrease in inflammation noted on examination. The patient who had the lens implant removed had return of his visual acuity to 20/25, has done well for over two years since fluconazole was stopped, and presumably is cured. The three patients in whom the lens implant was not removed did well while on fluconazole, but all relapsed with decreasing visual acuity four to five months after therapy was stopped. Two patients had vitreous aspiration performed four and five months after therapy was stopped, and both showed growth of C. parapsilosis on culture.
During fluconazole therapy the three patients

Discussion
Post-surgical Candida endophthalmitis is a subacute to chronic infection appearing weeks to months after surgery [2, 3, 111 . It mimics infection with other pathogens of low virulence, such as Propionobacterium acnes, which is found more frequently as a cause of post-operative endophthalmitis in patients with intraocular lens implants [3] . Post-surgical fungal endophthalmitis typically results in indolent, smouldering intraocular inflammation with mild pain and external signs similar to the findings with P. acnes infection. Pain, decreased visual acuity, and intraocular inflammation are also seen in postoperative, non-infectious uveitis, which is a more common complication than infection during the post-operative period. The similarity in findings between postoperative sterile uveitis and infection with pathogens of low virulence probably explains why all of our patients and most reported cases of postoperative Candida endophthalmitis were initially treated with corticosteroids. Although valuable in decreasing inflammation, it is likely that the use of corticosteroids increased the progression of Candida infection in these patients.
It is essential that in all cases of post-operative endophthalmitis cultures be performed to ascertain if micro-organisms are present. The highest yields are from vitreal aspirates or vitrectomy [2] . Organisms are often present in low numbers and need to be assiduously sought by appropriate culture techniques, including use of aerobic and anaerobic growth conditions and use of several different media to allow growth of both bacteria and fungi.
C. parapsilosis has been implicated in previous reports as a cause of post-operative endophthalmitis following cataract extraction alone [ 11, 121 and with intraocular lens implantation [ I , 2, 61.
Most notable was an outbreak of C. parapsilosis endophthalmitis traced to contaminated balanced salt solution used intra-operatively [ l , 21. Thirteen cases were documented to be culture positive for C. parapsilosis, and the implicated lot of irrigating solution also yielded C. parapsilosis [l] . All of these patients had an indolent postoperative endophthalmitis with symptoms and signs similar to those noted in our patients.
Although a less common cause of fungaemia than C. albicans, C. parapsilosis is frequently implicated as a cause of infection in patients receiving total parenteral nutrition and in those with prosthetic devices, and is often a nosocomially acquired infection [ 13-161. C. parapsilosis appears to be less pathogenic than C. albicans or C. tropicalis on the basis of experimental animal studies [13] , and patients with C. parapsilosis fungaemia appear to have a lower mortality than those with fungaemia due to C. albicans and C. tropicalis [ 13, 14, Post-surgical exogenously acquired Candida endophthalmitis appears to be more difficult to treat than haematogenously acquired infection [21] . The infection is usually very low grade with minimal inflammation, thus leading to low concentrations of antifungal drugs in the tissues [7, 91 . Also, the presence of a foreign body, in the case of infection following intraocular lens implantation, makes eradication of fungal infection difficult [3, 41 . One additional point that may be important is that although Candida infection may be sight-threatening, many patients and physicians are unwilling to use long-term systemic amphotericin B to treat this localized infection [2, 7, 201 . This is especially true in elderly individuals, who receive most intraocular lens implants, and who are more likely to have preexisting renal insufficiency and tolerate amphotericin B less well [22] . [ 101. These results confirmed those of Savani et al. [9] , who showed in rabbits that fluconazole penetrated the aqueous humour and vitreous body even in the absence of inflammation, an important point in patients such as ours with low-grade inflammation.
However, data obtained in rabbits with experimental Candida endophthalmitis raise questions about the efficacy of fluconazole in treating Candida endophthalmitis [9, 191 . Fluconazole proved to be less effective than either amphotericin B or other azoles, even though higher drug levels were measured for fluconazole than for the other drugs [9, 191. [23] . Although all of our patients improved clinically, only one, the patient who had the lens implant removed, was cured. If at all possible, both removal of the foreign body and antifungal therapy should be carried out to enhance the possibility for a cure. If it is difficult to remove the implant, as occurred with several of our elderly patients, then chronic suppression with a relatively non-toxic oral drug, such as fluconazole, is a reasonable option. I n this case, therapy probably should be continued for life to suppress recurrence of the infection.
